MetaCap

AngioDynamics (ANGO) vs Avita Medical (RCEL)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Avita Medical (RCEL) has outperformed AngioDynamics (ANGO) over the past year, gaining 312.1% versus a loss of 9.5%. Over five years, RCEL leads with a +10.8% price change compared with -60.3% for ANGO. Avita Medical is the larger company by market cap ($495.0 million vs $454.6 million), about 1.1 times the size.

AngioDynamics converts more of its revenue into profit, with a net margin of -11.5% versus -67.8%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

ANGO-9.54%RCEL+312.14%
+385%+173%-38%
Nov 21, 20251 yearNov 20, 2026
ANGO-62.10%RCEL+4.20%
+45%-21%-87%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

ANGO versus RCEL key metrics
MetricANGORCEL
Share price$10.81$15.62
Market cap$454.61M$494.96M
1-day change+0.46%-2.31%
YTD return-15.81%+352.75%
1-year return-9.54%+312.14%
5-year return-60.29%+10.78%
EPS (TTM)$-0.78$-1.17
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$320.17M$71.61M
Revenue growth (YoY)+9.46%+11.45%
Net income (latest FY)$-36.74M$-48.59M
Gross margin54.62%82.13%
Operating margin-12.47%-59.40%
Net margin-11.48%-67.85%
52-week high$16.29$18.43
52-week low$9.39$3.22
Distance from 52-week high-33.64%-15.25%
Analyst consensusnonestrong_buy
Avg. price target upside+82.70%+32.46%
Average volume651.16K417.02K
Shares outstanding42.05M31.69M
Employees632226
SectorHealth CareHealth Care
IndustryMedical/Dental InstrumentsMedical/Dental Instruments

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • RCEL has outperformed ANGO by 321.7 percentage points over the past year.
  • AngioDynamics is more profitable, keeping -11.5 cents of every revenue dollar as net income versus -67.8 cents for Avita Medical.

About AngioDynamics

ANGO stock →

AngioDynamics, Inc., a medical technology company, designs, manufactures, and sells products for the treatment of cardiovascular disease and cancer diagnoses in the United States and internationally. The company operates through Med Tech and Med Device segments.

Health Care · Medical/Dental Instruments · 632 employees

About Avita Medical

RCEL stock →

AVITA Medical, Inc., together with its subsidiaries, operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds and full-thickness skin defects, as well as for repigmentation of stable depigmented vitiligo lesions.

Health Care · Medical/Dental Instruments · 226 employees

ANGO vs RCEL FAQ

Which is bigger, AngioDynamics or Avita Medical?

Avita Medical (RCEL) is larger, with a market capitalization of $494.96M compared with $454.61M for AngioDynamics (ANGO).

Which stock has performed better over the past year, ANGO or RCEL?

RCEL returned +312.14% over the past 12 months, compared with -9.54% for ANGO (price return, excluding dividends). Past performance does not predict future results.

Are AngioDynamics and Avita Medical in the same industry?

Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.

More comparisons